Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Iran J Med Sci. 2024 Apr 1;49(4):219-228. doi: 10.30476/ijms.2023.98201.3012. eCollection 2024 Apr.
Several studies assessed the relationship between the gene polymorphism (rs708272) with risk factors of cardiovascular diseases (CVDs). However, their findings were inconsistent. The present study investigated the relationship between CVD risk factors and the variant in patients undergoing coronary angiography.
This cross-sectional study was conducted on 476 patients aged 30-76 years old of both sexes from 2020-2021, in Yazd (Iran). The polymorphism genotypes were evaluated using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) on DNA extracted from whole blood. Standard protocols were used to measure cardio-metabolic markers. To determine the association between CVDs risk factors and the rs708272 variant, binary logistic regression was used in crude and adjusted models.
polymorphism genotype frequencies were 10.7% for B1B1, 72.3% for B1B2, and 17% for B2B2. There was no significant association between abnormal levels of CVDs risk factors and different genotypes of the variant, Gensini score (P=0.64), Syntax score (P=0.79), systolic blood pressure (P=0.55), diastolic blood pressure (P=0.58), and waist circumference (P=0.79). There was no significant association between genotypes of the rs708272 variant and any abnormal serum lipid levels. After adjusting for confounders, the results remained non-significant.
There was no significant association between CVDs risk factors and rs708272 polymorphism. The relationship between gene variants and CVD occurrences varied across groups, implying that more research in different regions is required.A preprint version of this manuscript is available at https://www.researchsquare.com/article/rs-2575215/v1 with doi: 10.21203/rs.3.rs-2575215/v1.
多项研究评估了基因多态性(rs708272)与心血管疾病(CVDs)危险因素之间的关系。然而,他们的发现并不一致。本研究旨在调查在接受冠状动脉造影的患者中,CVD 危险因素与变异之间的关系。
这是一项横断面研究,于 2020 年至 2021 年期间在伊朗亚兹德对 476 名年龄在 30-76 岁的男女患者进行,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法从全血中提取 DNA 评估多态性基因型。采用标准方案测量心血管代谢标志物。为了确定 CVDs 危险因素与 rs708272 变异之间的关联,采用二元逻辑回归法在粗模型和调整模型中进行分析。
B1B1 基因型频率为 10.7%,B1B2 基因型频率为 72.3%,B2B2 基因型频率为 17%。不同 rs708272 变异基因型与 CVDs 危险因素异常水平之间无显著相关性,包括 Gensini 评分(P=0.64)、Syntax 评分(P=0.79)、收缩压(P=0.55)、舒张压(P=0.58)和腰围(P=0.79)。不同 rs708272 变异基因型与任何异常血清脂质水平之间也无显著相关性。调整混杂因素后,结果仍无统计学意义。
CVDs 危险因素与 rs708272 多态性之间无显著相关性。基因变异与 CVD 发生之间的关系因人群而异,这表明需要在不同地区进行更多的研究。预印本版本的手稿可在 https://www.researchsquare.com/article/rs-2575215/v1 上获得,doi: 10.21203/rs.3.rs-2575215/v1.